KEGG   PATHWAY: clud04115
Entry
clud04115                   Pathway                                
Name
p53 signaling pathway - Canis lupus dingo (dingo)
Description
p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator of p53-regulated genes. This results in three major outputs; cell cycle arrest, cellular senescence or apoptosis. Other p53-regulated gene functions communicate with adjacent cells, repair the damaged DNA or set up positive and negative feedback loops that enhance or attenuate the functions of the p53 protein and integrate these stress responses with other signal transduction pathways.
Class
Cellular Processes; Cell growth and death
Pathway map
clud04115  p53 signaling pathway
clud04115

Organism
Canis lupus dingo (dingo) [GN:clud]
Gene
112671393  ATM; serine-protein kinase ATM isoform X1 [KO:K04728] [EC:2.7.11.1]
112676766  CHEK2; LOW QUALITY PROTEIN: serine/threonine-protein kinase Chk2 [KO:K06641] [EC:2.7.11.1]
112660963  ATR; serine/threonine-protein kinase ATR isoform X1 [KO:K06640] [EC:2.7.11.1]
112671112  CHEK1; serine/threonine-protein kinase Chk1 isoform X1 [KO:K02216] [EC:2.7.11.1]
112648642  GORAB; RAB6-interacting golgin isoform X1 [KO:K19748]
112677878  MDM2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
112643240  MDM4; protein Mdm4 isoform X1 [KO:K10127]
112647438  TP53; cellular tumor antigen p53 [KO:K04451]
112645299  PPP1R13L; relA-associated inhibitor isoform X1 [KO:K27356]
112641497  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
112663184  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
112669048  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
112641579  CCND3; G1/S-specific cyclin-D3 isoform X2 [KO:K10152]
112677962  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
112654545  LOW QUALITY PROTEIN: cyclin-dependent kinase 4-like [KO:K02089] [EC:2.7.11.22]
112674930  CDK6; cyclin-dependent kinase 6 isoform X1 [KO:K02091] [EC:2.7.11.22]
112645606  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
112650816  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
112678040  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
112659872  SFN; 14-3-3 protein sigma [KO:K06644]
112674751  RPRM; protein reprimo [KO:K10128]
112660631  CCNB1; G2/mitotic-specific cyclin-B1 [KO:K05868]
125753218  G2/mitotic-specific cyclin-B1 [KO:K05868]
112675843  CCNB2; G2/mitotic-specific cyclin-B2 isoform X1 [KO:K21770]
112651419  CDK1; cyclin-dependent kinase 1 [KO:K02087] [EC:2.7.11.22 2.7.11.23]
112644859  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
112641088  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
112666236  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
112665964  GTSE1; G2 and S phase-expressed protein 1 isoform X1 [KO:K10129]
112667151  ZNF385A; LOW QUALITY PROTEIN: zinc finger protein 385A [KO:K26543]
112656223  FAS; tumor necrosis factor receptor superfamily member 6 isoform X2 [KO:K04390]
112663256  PIDD1; LOW QUALITY PROTEIN: p53-induced death domain-containing protein 1 [KO:K10130]
112656364  CASP8; caspase-8 isoform X1 [KO:K04398] [EC:3.4.22.61]
112667429  LOW QUALITY PROTEIN: BH3-interacting domain death agonist [KO:K04726]
118352478  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
112645177  BAX; apoptosis regulator BAX [KO:K02159]
112644049  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
112645247  BBC3; bcl-2-binding component 3 [KO:K10132]
112658033  SIVA1; LOW QUALITY PROTEIN: apoptosis regulatory protein Siva [KO:K22744]
112643689  LOW QUALITY PROTEIN: apoptosis regulatory protein Siva-like [KO:K22744]
112673768  BCL2L1; bcl-2-like protein 1 [KO:K04570]
112644027  BCL2; apoptosis regulator Bcl-2 isoform X2 [KO:K02161]
112664713  TP53I3; quinone oxidoreductase PIG3 [KO:K10133] [EC:1.-.-.-]
112671114  EI24; etoposide-induced protein 2.4 homolog [KO:K10134]
112644397  LOW QUALITY PROTEIN: etoposide-induced protein 2.4 homolog [KO:K10134]
112665746  SHISA5; protein shisa-5 isoform X1 [KO:K10135]
112644183  p53 apoptosis effector related to PMP-22 [KO:K10136]
112662677  ZMAT3; zinc finger matrin-type protein 3 isoform X1 [KO:K10137]
112659890  SIAH1; E3 ubiquitin-protein ligase SIAH1 isoform X1 [KO:K04506] [EC:2.3.2.27]
112670591  cytochrome c [KO:K08738]
112678206  LOW QUALITY PROTEIN: cytochrome c-like [KO:K08738]
112653556  LOW QUALITY PROTEIN: cytochrome c-like [KO:K08738]
112654697  APAF1; apoptotic protease-activating factor 1 isoform X1 [KO:K02084]
112659987  CASP9; caspase-9 isoform X1 [KO:K04399] [EC:3.4.22.62]
112675231  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
112651243  AIFM2; ferroptosis suppressor protein 1 isoform X1 [KO:K22745]
112650981  IGFBP3; insulin-like growth factor-binding protein 3 [KO:K10138]
112654388  IGF1; insulin-like growth factor I isoform X2 [KO:K05459]
112646212  SERPINE1; plasminogen activator inhibitor 1 [KO:K03982]
112662057  ADGRB1; adhesion G protein-coupled receptor B1 isoform X4 [KO:K04596]
112663260  CD82; CD82 antigen isoform X2 [KO:K06509]
112676140  THBS1; thrombospondin-1 [KO:K16857]
112644023  SERPINB5; serpin B5 isoform X1 [KO:K10139]
112663311  DDB2; DNA damage-binding protein 2 isoform X2 [KO:K10140]
112661977  RRM2B; ribonucleoside-diphosphate reductase subunit M2 B isoform X2 [KO:K10808] [EC:1.17.4.1]
112664844  RRM2; ribonucleoside-diphosphate reductase subunit M2 [KO:K10808] [EC:1.17.4.1]
112658727  SESN1; sestrin-1 isoform X1 [KO:K10141]
112641987  SESN3; sestrin-3 isoform X1 [KO:K10141]
112660160  SESN2; sestrin-2 [KO:K20394]
112656209  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X3 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
112640546  TSC2; tuberin isoform X1 [KO:K07207]
112648043  STEAP3; metalloreductase STEAP3 [KO:K10142] [EC:1.16.1.-]
112648568  COP1; E3 ubiquitin-protein ligase COP1 isoform X1 [KO:K10143] [EC:2.3.2.27]
112647158  RCHY1; RING finger and CHY zinc finger domain-containing protein 1 isoform X1 [KO:K10144] [EC:2.3.2.27]
112651238  CCNG1; cyclin-G1 isoform X1 [KO:K10145]
112646837  CCNG2; cyclin-G2 [KO:K10146]
112655140  PPM1D; protein phosphatase 1D isoform X1 [KO:K10147] [EC:3.1.3.16]
112646954  TP73; tumor protein p73 isoform X4 [KO:K10148]
Reference
  Authors
Levine AJ, Hu W, Feng Z.
  Title
The P53 pathway: what questions remain to be explored?
  Journal
Cell Death Differ 13:1027-36 (2006)
DOI:10.1038/sj.cdd.4401910
Reference
  Authors
Harris SL, Levine AJ.
  Title
The p53 pathway: positive and negative feedback loops.
  Journal
Oncogene 24:2899-908 (2005)
DOI:10.1038/sj.onc.1208615
Reference
  Authors
Balint E E, Vousden KH.
  Title
Activation and activities of the p53 tumour suppressor protein.
  Journal
Br J Cancer 85:1813-23 (2001)
DOI:10.1054/bjoc.2001.2128
Reference
  Authors
Taylor WR, Stark GR.
  Title
Regulation of the G2/M transition by p53.
  Journal
Oncogene 20:1803-15 (2001)
DOI:10.1038/sj.onc.1204252
Reference
  Authors
Hofseth LJ, Hussain SP, Harris CC.
  Title
p53: 25 years after its discovery.
  Journal
Trends Pharmacol Sci 25:177-81 (2004)
DOI:10.1016/j.tips.2004.02.009
Reference
  Authors
Pietenpol JA, Stewart ZA.
  Title
Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis.
  Journal
Toxicology 181-182:475-81 (2002)
DOI:10.1016/S0300-483X(02)00460-2
Reference
  Authors
Tokino T, Nakamura Y.
  Title
The role of p53-target genes in human cancer.
  Journal
Crit Rev Oncol Hematol 33:1-6 (2000)
DOI:10.1016/S1040-8428(99)00051-7
Reference
  Authors
Hermeking H, Benzinger A.
  Title
14-3-3 proteins in cell cycle regulation.
  Journal
Semin Cancer Biol 16:183-92 (2006)
DOI:10.1016/j.semcancer.2006.03.002
Reference
  Authors
Sherr CJ.
  Title
Divorcing ARF and p53: an unsettled case.
  Journal
Nat Rev Cancer 6:663-73 (2006)
DOI:10.1038/nrc1954
Reference
  Authors
Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ.
  Title
The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
  Journal
Cancer Res 67:3043-53 (2007)
DOI:10.1158/0008-5472.CAN-06-4149
Reference
  Authors
Resnick-Silverman L, Manfredi JJ
  Title
Two Faces of SIVA.
  Journal
Cancer Discov 5:581-3 (2015)
DOI:10.1158/2159-8290.CD-15-0484
Reference
  Authors
Resch U, Schichl YM, Winsauer G, Gudi R, Prasad K, de Martin R
  Title
Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis.
  Journal
J Cell Sci 122:2651-61 (2009)
DOI:10.1242/jcs.049940
Reference
  Authors
Barkinge JL, Gudi R, Sarah H, Chu F, Borthakur A, Prabhakar BS, Prasad KV
  Title
The p53-induced Siva-1 plays a significant role in cisplatin-mediated apoptosis.
  Journal
J Carcinog 8:2 (2009)
DOI:10.4103/1477-3163.45389
Reference
  Authors
Ohiro Y, Garkavtsev I, Kobayashi S, Sreekumar KR, Nantz R, Higashikubo BT, Duffy SL, Higashikubo R, Usheva A, Gius D, Kley N, Horikoshi N
  Title
A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF).
  Journal
FEBS Lett 524:163-71 (2002)
DOI:10.1016/S0014-5793(02)03049-1
Reference
  Authors
Hu Y, Ge W, Wang X, Sutendra G, Zhao K, Dedeic Z, Slee EA, Baer C, Lu X
  Title
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-kappaB.
  Journal
Oncotarget 6:42478-90 (2015)
DOI:10.18632/oncotarget.6478
Related
pathway
clud04110  Cell cycle
clud04210  Apoptosis
clud04218  Cellular senescence
KO pathway
ko04115   
LinkDB

DBGET integrated database retrieval system